What does MICROSANG do?

MICROSANG is a specialist medical practice in Deerlijk. Private Limited, started on 6 July 2021, 1 establishment.

What is the address of MICROSANG?

The registered office of MICROSANG is located at Desselgemse steenweg 86, 8540 Deerlijk.

Is MICROSANG still active?

Yes. According to the CBE (15 November 2026) MICROSANG is active, legal situation “Normale toestand”, started on 6 July 2021.

Is MICROSANG registered on Peppol?

Yes, MICROSANG is registered on the Peppol network with ID 0208:0770818517.

What is the enterprise number of MICROSANG?

The enterprise number of MICROSANG is BE0770818517.

When was MICROSANG founded?

MICROSANG was founded on 6 July 2021.

Who are the directors of MICROSANG?

According to the 2025 annual accounts, the directors of MICROSANG are: Rutger Callens, Sofie Colman.

Is MICROSANG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 July 2021; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did MICROSANG make in 2025?

MICROSANG posted a profit after taxes of € 385,891 in financial year 2025.

What is the revenue of MICROSANG?

As a small company, MICROSANG is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 528,353.

MICROSANG (Private Limited) - Deerlijk - BE0770818517

Dossier MICROSANG, printed on 15 November 2026 from databakkes.be/en/0770818517/microsang. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MICROSANG from Deerlijk, company number BE0770818517, closed financial year 2025 with a result of € 385,891 after tax. For that financial year MICROSANG recorded a gross margin of € 528,353 and equity of € 4,037. Compared with financial year 2024, the result moved from € 320,237 to € 385,891. Profitable, and profit is growing. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 15, 2026.

What it is worth Shrank hard

€ 4,037

▼ 99% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 385,891

▲ 21% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 303,743

▼ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 1 million paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 2,528

▼ 80% vs 2024

Of which on lease € 2,137.

Debts at end 2025

Bank debt

€ 2,364

▼ 80% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 5,062

▲ 32% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 66,794

▲ 221% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 151,160 Gross margin 2022: € 151,160 First fiscal year in the series	€ 287,341 Gross margin 2023: € 287,341 ▲ 90% vs 2022 (€ 151,160) Favourable step	€ 444,796 Gross margin 2024: € 444,796 ▲ 55% vs 2023 (€ 287,341) Favourable step	€ 528,353 Gross margin 2025: € 528,353 ▲ 19% vs 2024 (€ 444,796) Favourable step	▲ 19%
Profit after taxes	€ 103,001 Profit after taxes 2022: € 103,001 First fiscal year in the series	€ 198,798 Profit after taxes 2023: € 198,798 ▲ 93% vs 2022 (€ 103,001) Favourable step	€ 320,237 Profit after taxes 2024: € 320,237 ▲ 61% vs 2023 (€ 198,798) Favourable step	€ 385,891 Profit after taxes 2025: € 385,891 ▲ 21% vs 2024 (€ 320,237) Favourable step	▲ 21%
Equity	€ 105,001 Equity 2022: € 105,001 First fiscal year in the series	€ 303,799 Equity 2023: € 303,799 ▲ 189% vs 2022 (€ 105,001) Favourable step	€ 624,036 Equity 2024: € 624,036 ▲ 105% vs 2023 (€ 303,799) Favourable step	€ 4,037 Equity 2025: € 4,037 ▼ 99% vs 2024 (€ 624,036) Unfavourable step	▼ 99%
Total debts	€ 84,818 Total debts 2022: € 84,818 First fiscal year in the series	€ 53,044 Total debts 2023: € 53,044 ▼ 37% vs 2022 (€ 84,818) Favourable step	€ 47,758 Total debts 2024: € 47,758 ▼ 10% vs 2023 (€ 53,044) Favourable step	€ 409,662 Total debts 2025: € 409,662 ▲ € 361,905 vs 2024 (€ 47,758) Unfavourable step	▲ € 361,905
Cash	€ 107,894 Cash 2022: € 107,894 First fiscal year in the series	€ 27,808 Cash 2023: € 27,808 ▼ 74% vs 2022 (€ 107,894) Unfavourable step	€ 323,643 Cash 2024: € 323,643 ▲ € 295,835 vs 2023 (€ 27,808) Favourable step	€ 303,743 Cash 2025: € 303,743 ▼ 6% vs 2024 (€ 323,643) Unfavourable step	▼ 6%
Retained profit	€ 103,001 Retained profit 2022: € 103,001 First fiscal year in the series	€ 301,799 Retained profit 2023: € 301,799 ▲ 193% vs 2022 (€ 103,001) Favourable step	€ 622,036 Retained profit 2024: € 622,036 ▲ 106% vs 2023 (€ 301,799) Favourable step	€ 2,037 Retained profit 2025: € 2,037 ▼ € 619,999 vs 2024 (€ 622,036) Unfavourable step	▼ € 619,999
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 1,005,890 Dividend 2025: € 1,005,890 Unchanged (€ 0) Unchanged
Bank debt	€ 30,292 Bank debt 2022: € 30,292 First fiscal year in the series	€ 21,074 Bank debt 2023: € 21,074 ▼ 30% vs 2022 (€ 30,292) Favourable step	€ 11,765 Bank debt 2024: € 11,765 ▼ 44% vs 2023 (€ 21,074) Favourable step	€ 2,364 Bank debt 2025: € 2,364 ▼ 80% vs 2024 (€ 11,765) Favourable step	▼ 80%
Balance sheet total	€ 189,819 Balance sheet total 2022: € 189,819 First fiscal year in the series	€ 356,843 Balance sheet total 2023: € 356,843 ▲ 88% vs 2022 (€ 189,819) Unchanged	€ 671,794 Balance sheet total 2024: € 671,794 ▲ 88% vs 2023 (€ 356,843) Unchanged	€ 413,699 Balance sheet total 2025: € 413,699 ▼ 38% vs 2024 (€ 671,794) Unchanged	▼ 38%

By gross margin, MICROSANG ranks 3rd of 6 companies with main activity “Activiteiten van medisch specialisten” in Deerlijk that publish figures (fiscal year 2025).

Key figures of MICROSANG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

Ask about MICROSANG the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to MICROSANG?

What happened at MICROSANG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 15, 2026 New annual accounts for financial year 2025: profit of € 385,891 (▲ 21% vs 2024). Source: NBB ↗
Jul 8, 2021 Incorporation, published in the Gazette. Source: Staatsblad ↗
Jul 6, 2021 New establishment in Deerlijk. KBO

In short

From € 103,001 profit in 2022 to € 385,891 profit in 2025.

Paid € 319,543 in corporate taxes since 2022.

Best year ever: 2025, with € 385,891 profit.

Paid out € 1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Rutger Callens Sofie Colman

MICROSANG

Behind MICROSANG are Rutger Callens and Sofie Colman.

Directors

According to the 2025 annual accounts

Rutger Callens

Director

Sofie Colman

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Desselgemse steenweg 86

8540 Deerlijk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Deerlijk

Same main activity (Activiteiten van medisch specialisten), 6 active companies in Deerlijk, largest first.

Dr. Steven Vandewaeter

€ 608,539 gross margin · 2025

DR. MICHELE DESNOECK

€ 554,909 gross margin · 2025

DOKTER MARLEEN DEZILLIE

€ 341,585 gross margin · 2025

Dr. Vulsteke Christof, medische oncologie

€ 236,689 gross margin · 2025

Dokter Charlotte Bosschaert

€ 108,519 gross margin · 2025

All companies with this activity → Largest companies in Deerlijk →

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

8 July 2021 Source: Deed ↗

CALLENS Rutger Luc Marijke(oprichter) 50%
COLMAN Sofie(oprichter) 50%

Details

Company number: 0770.818.517
VAT number: BE 0770.818.517
Registered office: Desselgemse steenweg 86, 8540 Deerlijk
Names & denominations: MICROSANG
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 July 2021
Peppol: Active · Active since 24 Nov 2023
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗